α-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study

Hepatology

Volumn 35, Issue 4, 2002, Pages 853-860

  Ijichi, Masayoshi ^a   Takayama, Tadatoshi ^a   Matsumura, Masayuki ^a,b   Shiratori, Yasushi ^a   Omata, Masao ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0036203231     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.32100     Document Type: Article

References (34)

1. Treatment of hepatocellular carcinoma
2. Early hepatocellular carcinoma as an entity with a high rate of surgical cure
3. Recurrence of hepatocellular carcinoma after surgery
4. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
5. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors
6. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis
7. Cancer cells in the blood
8. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
9. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma
10. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma
11. Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver
12. Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma
13. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery
14. Circulating albumin messenger RNA in hepatocellular carcinoma: Results of a multicenter prospective study
15. Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells
16. Surgery for small liver cancers
17. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood
18. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: A quantitative evaluation
19. Postoperative detection of α-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma
20. Albumin messenger RNA is not specific for circulating hepatoma cells
21. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells
22. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: A quantitative analysis
23. Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay: Its application for clinical use
24. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan
25. Ultrasonically guided subsegmentectomy
26. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma
27. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma
28. Does surgery disseminate or accelerate cancer?
29. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis
30. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous system during hepatic resection?
31. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma
32. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
33. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
34. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma